Design Therapeutics, Inc. (DSGN)
Design Therapeutics, Inc. is a biopharmaceutical company in the preclinical phase that focuses on creating treatments for genetic conditions stemming from nucleotide repeat expansions. Its current pipeline targets Friedreich's Ataxia (FA), a severe, progressive, monogenic, and autosomal recessive disease. FA primarily impairs mitochondrial function across various organ systems, resulting in neurological, cardiac, and metabolic complications. Another significant area of development is Myotonic Dystrophy Type-1 (DM1). This is a progressive, dominantly inherited monogenic neuromuscular illness that impacts skeletal muscle, the heart, brain, and other bodily systems. Beyond these, the company is advancing its GeneTAC product candidate platform to address an array of other monogenic conditions caused by nucleotide repeat expansions. These include Fragile X syndrome, various spinocerebellar ataxias, amyotrophic lateral sclerosis (ALS), frontotemporal dementia, Huntington's disease, and spinobulbar muscular atrophy. Established in 2017, Design Therapeutics, Inc. maintains its headquarters in Carlsbad, California.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Design Therapeutics, Inc.
NASDAQ:DSGNHealthcare · Biotechnology
-3.44%$10.68
AH$10.68+0.00%vs close
Mkt Cap$668.37M
Float30.5M
O/S62.58M
Vol
$ Vol
RVOL
Inst Own69.3%
SI21.8%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$69.79M
Total Assets$226.2M
Free Cash Flow-$54.55M
Debt & Equity
Debt 1%
Equity 99%
Total Debt$1.53M
Total Equity$212.5M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in DSGN's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$226.2M
Liabilities$13.7M
Accounts Receivable$1.68M
Accounts Payable$2.31M
Inventory$0
PP&E (Net)$2.42M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $834 |
| YoY Growth | - | - | - | - | - | - | - |
| Cost of Revenue | $0 | $0 | $537K | $466K | $0 | $5K | $2K |
| Gross Profit | $0 | $0 | -$537K | -$466K | $0 | -$5K | -$820 |
| Gross Margin | - | - | - | - | - | - | -98.3% |
| Research and Development | $59.13M | $44.35M | $57.06M | $48.61M | $24.78M | $6.06M | $1.65M |
| Selling, General, and Administrative | $20.34M | $18.03M | $21.13M | $18.98M | $11.05M | $2.5M | $1.09M |
| Other | $0 | $0 | -$537K | -$466K | $0 | $0 | -$834K |
| Total Operating Expenses | $79.47M | $62.38M | $77.65M | $67.13M | $35.83M | $8.55M | $1.91M |
| Operating Income (EBIT) | -$79.47M | -$62.38M | -$78.19M | -$67.59M | -$35.83M | -$8.56M | -$1.91M |
| Operating Margin | - | - | - | - | - | - | -228777.0% |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $9.68M | $12.79M | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | $9.68M | $12.79M | $11.33M | $4.29M | $298K | $276K | -$139K |
| Income Before Tax (EBT) | -$69.79M | -$49.59M | -$66.86M | -$63.31M | -$35.53M | -$8.28M | -$2.05M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$69.79M | -$49.59M | -$66.86M | -$63.31M | -$35.53M | -$8.28M | -$2.05M |
| Net Income Margin | - | - | - | - | - | - | -245443.6% |
| Supplementary Data | |||||||
| EPS | -1.22 | -0.88 | -1.19 | -1.14 | -0.77 | -0.30 | -0.08 |
| Diluted EPS | -1.22 | -0.88 | -1.19 | -1.14 | -0.77 | -0.30 | -0.08 |
| Weighted Average OS | 57.33M | 56.59M | 55.98M | 55.71M | 45.94M | 27.19M | 27.19M |
| EBITDA | -$69.17M | -$48.99M | -$66.33M | -$62.9M | -$35.4M | -$8.28M | -$139K |
| EBITDA Margin | - | - | - | - | - | - | -16666.7% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Assets | |||||||
| Current Assets | |||||||
| Cash and Cash Equivalents | $16.86M | $22.56M | $21.2M | $26.5M | $298.57M | $2.38M | $77K |
| Short-Term Investments | $202.99M | $222.91M | $260.6M | $303.89M | $85.5M | $33.71M | $0 |
| Cash and Short-Term Investments | $219.84M | $245.48M | $281.8M | $330.39M | $384.06M | $36.09M | $77K |
| Accounts Receivable | $1.68M | $1.26M | $1.43M | $1.11M | $110K | $10K | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $0 | $0 | $0 | $0 | $0 | $25K | $8K |
| Total Current Assets | $223.78M | $248.04M | $284.58M | $335.12M | $385.44M | $36.23M | $90K |
| Long-Term Assets | |||||||
| Property, Plant & Equipment Net | $2.42M | $3.63M | $4.63M | $5.56M | $5.12M | $71K | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $427K | $430K | $459K | $0 | $212K | $0 |
| Total Long-Term Assets | $2.42M | $4.05M | $5.06M | $6.02M | $5.12M | $283K | $0 |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $226.2M | $252.09M | $289.64M | $341.14M | $390.56M | $36.52M | $90K |
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts Payable | $2.31M | $2.19M | $1.94M | $3.02M | $1.62M | $1.4M | $2.48M |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $695K |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $201K |
| Other Current Liabilities | $4.63M | $3.58M | $4.03M | $3.54M | $2.15M | $565K | $112K |
| Total Current Liabilities | $13.05M | $8.46M | $9.62M | $10.78M | $5.28M | $2.33M | $3.73M |
| Long-Term Liabilities | |||||||
| Long-Term Debt | $645K | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $45.5M | $1K |
| Total Long-Term Liabilities | $645K | $1.53M | $2.33M | $3.05M | $3.14M | $45.5M | $1K |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $13.7M | $10M | $11.96M | $13.83M | $8.43M | $47.83M | $3.73M |
| Stockholders' Equity | |||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $45.36M | $0 |
| Common Stock | $6K | $6K | $6K | $6K | $6K | $1K | $1K |
| Retained Earnings | -$297.01M | -$227.21M | -$177.63M | -$110.76M | -$47.46M | -$11.92M | -$3.64M |
| Comprehensive Income & Other | $403K | $475K | $62K | -$3.36M | -$244K | $156K | $0 |
| Other Stockholders' Equity | $509.5M | $469.31M | $455.31M | $438.07M | $429.58M | $607K | $0 |
| Total Equity | $212.5M | $242.1M | $277.69M | $327.31M | $382.13M | -$11.31M | -$3.64M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $226.2M | $252.09M | $289.64M | $341.14M | $390.56M | $36.52M | $90K |
| Supplementary Data | |||||||
| Total Debt | $1.53M | $2.33M | $3.05M | $3.69M | $3.63M | $0 | $695K |
| Net Debt | -$15.32M | -$20.23M | -$18.15M | -$22.81M | -$294.94M | -$2.38M | $618K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Operating Activities | |||||||
| Net Income | -$69.79M | -$49.59M | -$66.86M | -$63.31M | -$35.53M | -$8.28M | -$2.05M |
| Depreciation & Amortization | $622K | $596K | $537K | $406K | $129K | $5K | $1.91M |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $14.55M | $13.07M | $13.09M | $10.93M | $4.69M | $450K | $0 |
| Changes in Working Capital: | |||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $4.49M | -$1.22M | -$1.25M | $5.38M | $2.41M | -$413K | $0 |
| Other Working Capital | -$1.38M | $226K | $1.97M | -$3.39M | -$1.02M | -$398K | $1.81M |
| Total Working Capital Change | $3.11M | -$993K | $728K | $1.99M | $1.4M | -$811K | $1.81M |
| Other Non-Cash Items | -$2.85M | -$6.19M | -$6.05M | -$1.33M | -$58K | -$33K | -$1.81M |
| Net Cash from Operating | -$54.36M | -$43.1M | -$58.56M | -$51.32M | -$29.38M | -$8.67M | -$139K |
| Investing Activities | |||||||
| Capital Expenditures | -$193K | -$340K | -$256K | -$918K | -$1.54M | -$76K | $0 |
| Acquisitions | $0 | $0 | $0 | $39K | $52K | $0 | $0 |
| Purchases of Investments | -$291.78M | -$230.18M | -$224.7M | -$313M | -$86.26M | -$55.59M | $0 |
| Sales of Investments | $314.88M | $274.47M | $277.5M | $92.89M | $34.16M | $22.1M | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | -$52K | $0 | $0 |
| Net Cash from Investing | $22.91M | $43.95M | $52.54M | -$220.99M | -$53.64M | -$33.56M | $0 |
| Financing Activities | |||||||
| Debt Repaid | - | - | - | - | - | $200K | -$196K |
| Common Stock Issuance | $25.74M | $513K | $724K | $662K | $254.27M | $0 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | $0 | -$427K | $228K | $1K | $0 |
| Net Cash from Financing | $25.74M | $513K | $724K | $235K | $379.21M | $44.53M | $196K |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$5.71M | $1.36M | -$5.3M | -$272.07M | $296.19M | $2.3M | $57K |
| Supplementary Data | |||||||
| Operating Cash Flow | -$54.36M | -$43.1M | -$58.56M | -$51.32M | -$29.38M | -$8.67M | -$139K |
| Capital Expenditure | -$193K | -$340K | -$256K | -$918K | -$1.54M | -$76K | $0 |
| Free Cash Flow | -$54.55M | -$43.45M | -$58.82M | -$52.23M | -$30.91M | -$8.74M | -$139K |
| Cash at Beginning | $22.56M | $21.2M | $26.5M | $298.57M | $2.38M | $77K | $20K |
| Cash at End | $16.86M | $22.56M | $21.2M | $26.5M | $298.57M | $2.38M | $77K |